| ADHD Groups (Na=85) | Controls (N=26) | |||
| Drug-free (N=44) | Atomoxetine (N=23) | Methilfhenydate (N=18) | ||
| Type of ADHD | ||||
| Inattentive N(%) | 7(8.2%) | - | 2(2.4%) | - |
| Hyperactive/Impulsive N(%) | 1(1.2%) | - | 2(2.4%) | - |
| Combined N(%) | 36(42.4 %) | 23(27%) | 14(16.5%) | - |
| Comorbid disorders | ||||
| SLDb N (%) | 17(20%) | 1(1.2%) | 9(10.6%) | - |
| Anxiety Disorder N (%) | 18(21.2%) | 4(4.7%) | 4(4.7%) | - |
| ODDc N(%) | 7(8.2%) | 9(10.6%) | 9(10.6%) | - |
| Depressive Disorder N(%) | 3(3.6%) | 1(1.2%) | 1(1.2%) | - |
| Other | 3(3.5%) | 3(3.6%) | - | - |
| SNAP-IV Subscales | ||||
| Inattentive Md(SDe) | 18.13 (4.7) | 19.63 (4.3) | 17.00 (5.1) | 5.04 (1.1) |
| Hyperactive/Impulsive M (SD) | 15.67 (6.4) | 19.58 (4.8) | 14.85 (6.3) | 3.04 (1.1) |
| Combined M(SD) | 33.80 (9.9) | 39.21 (6.7) | 31.84 (9.6) | 8.08 (1.5) |
| Oppositional Defiant M(SD) | 11.00 (5.0) | 13.52 (5.5) | 12.15 (5.2) | 4.15 (1.3) |